A. T. Jannuzzı Et Al. , "Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling," Chemical Biology and Drug Design , vol.102, no.5, pp.1133-1154, 2023
Jannuzzı, A. T. Et Al. 2023. Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling. Chemical Biology and Drug Design , vol.102, no.5 , 1133-1154.
Jannuzzı, A. T., Yılmaz Göler, A. M., Shilkar, D., Mondal, S., Basavanakatti, V. N., Yıldırım, H., ... Yıldız, M.(2023). Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling. Chemical Biology and Drug Design , vol.102, no.5, 1133-1154.
Jannuzzı, Ayşe Et Al. "Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling," Chemical Biology and Drug Design , vol.102, no.5, 1133-1154, 2023
Jannuzzı, Ayşe T. Et Al. "Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling." Chemical Biology and Drug Design , vol.102, no.5, pp.1133-1154, 2023
Jannuzzı, A. T. Et Al. (2023) . "Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling." Chemical Biology and Drug Design , vol.102, no.5, pp.1133-1154.
@article{article, author={Ayşe Tarbın Jannuzzı Et Al. }, title={Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling}, journal={Chemical Biology and Drug Design}, year=2023, pages={1133-1154} }